Summary & Overview
HCPCS C9812: Echogenic Nerve Block Needle, Non-Opioid Device
HCPCS Level II code C9812 designates echogenic nerve block needles — sonoplex, sonoblock, sonotap — classified as qualifying non-opioid medical devices for post-surgical pain relief under section 4135 of the CAA, 2023. The code captures devices used to improve visualization during ultrasound-guided peripheral nerve blockade, supporting multimodal analgesia strategies that can reduce reliance on opioids after surgery. Nationally, this code matters as payers and Medicare implement coverage and payment pathways for new non-opioid technologies that address the opioid crisis and enhance postoperative pain management.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of the clinical role of echogenic needles, expected sites of service (operating rooms, ambulatory surgery centers, procedure suites), and the policy context tied to the CAA, 2023. The publication outlines typical billing considerations, payer coverage themes, and related coding context where available. Data not available in the input is noted where specific payer policies, modifiers, taxonomies, ICD-10 mappings, and related codes would normally be detailed. This summary equips clinicians, billing staff, and policy analysts with a national-level briefing on C9812 and what to expect when documenting and billing for echogenic nerve block needles as qualifying non-opioid devices.
Billing Code Overview
HCPCS Level II code C9812 describes echogenic nerve block needles, examples include sonoplex, sonoblock, and sonotap. These are non-opioid medical devices intended for post-surgical pain relief and must qualify as a Medicare non-opioid medical device in accordance with section 4135 of the CAA, 2023.
Service type: Device for image-guided peripheral nerve blockade used to facilitate regional anesthesia or analgesia during and after surgical procedures.
Typical site of service: Hospital operating rooms, ambulatory surgery centers, and procedure suites where intraoperative or perioperative regional nerve block techniques are performed.
Clinical & Coding Specifications
Clinical Context
A 54-year-old woman undergoes elective total knee arthroplasty for advanced osteoarthritis. Per the surgeon's perioperative pain plan and in accordance with the 2023 CAA non-opioid device provision, an anesthesiologist performs ultrasound-guided peripheral nerve blockade using an echogenic nerve block needle (e.g., Sonoplex) immediately prior to surgery in the preoperative block room. The patient is positioned supine; standard monitoring and IV access are established. Under sterile technique, ultrasound visualization of the femoral and adductor canal region is obtained. Local anesthetic is deposited adjacent to the targeted nerves using the echogenic needle to facilitate needle visualization, improve accuracy of perineural placement, and reduce procedural time and complications. The block provides post-surgical analgesia and reduces inpatient opioid requirements. The device is single-use and documented in the operative/anesthesia record with model/name, lot number, and confirmation that it met qualifying criteria for Medicare non-opioid medical devices per section 4135 of the CAA, 2023. Post-block evaluation documents sensory and motor effects, any immediate complications, and instructions for postoperative analgesia and monitoring.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician/anesthesiologist professional component of a service when the technical component is billed separately. |